Stockreport

Cantor Fitzgerald Maintains a Buy Rating on Crinetics Pharmaceuticals (CRNX) [Yahoo! Finance]

Crinetics Pharmaceuticals, Inc.  (CRNX) 
Last crinetics pharmaceuticals, inc. earnings: 3/9 04:10 pm Check Earnings Report
PDF analyst Joshua Schimmer maintained a Buy rating on Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) and set a price target of $90.00. Is Crinetics Pharmaceuticals Inc. (C [Read more]